Pharma Journalist -

Eli Lilly and Company and Incyte announced the U.S. Food and Drug Administration (FDA) has broadened the Emergency Use Authorization (EUA) for baricitinib to allow for treatment with or…
Read More...

Melior Pharmaceuticals (Melior) announced that it completed a definitive licensing agreement with Adhera Therapeutics, Inc . for Melior’s Parkinson’s disease (PD) candidate, MLR-1019…
Read More...

The new 𝐍𝐞𝐮𝐫𝐨𝐩𝐚𝐭𝐡𝐢𝐜 𝐏𝐚𝐢𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐒𝐮𝐦𝐦𝐢𝐭 𝟐𝟎𝟐𝟏 is the only industry-dedicated event focused on discovering novel #neuropathicpain drug targets, identifying quantitative #biomarkers…
Read More...

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced four new ready-to-use AlphaLISA KRAS kits, designed to help scientists better…
Read More...

Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced the closing of a $180 million Series C financing round. SoftBank Vision Fund 2* led the financing…
Read More...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced they have signed a Joint Procurement Agreement with the European Commission to supply up to 220,000 doses of sotrovimab, an…
Read More...

National Resilience, Inc. (Resilience) and bluebird bio, Inc. announced a strategic alliance aimed to accelerate the early research, development and delivery of cell therapies. As part…
Read More...

Amgen and Teneobio announced an agreement under which Amgen will acquire Teneobio, a privately held, clinical stage biotechnology company developing a new class of biologics called…
Read More...

SMi reports: Running alongside the main conference will be an interactive pre-conference workshop on 21st September 2021 on 'Target Discovery for RNA Therapeutics' Workshop Leader:…
Read More...

SMi Reports: Bringing together leading experts in the industry offering insights into device innovations, connected delivery and regulatory guidance for advanced parenteral systems.…
Read More...